Inventor
BERTENSHAW DEBORAH E
US32 patents
⚠️ This page may combine multiple inventors who share the name “BERTENSHAW DEBORAH E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEARLE & CO
21 patentsUS6248775B1Jun 19, 2001
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO129 citations99
US6060476AMay 9, 2000
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO77 citations97
US6500832B1Dec 31, 2002
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO21 citations96
US6455581B1Sep 24, 2002
α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO20 citations96
US5968942AOct 19, 1999
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO61 citations96
US5648511AJul 15, 1997
Method for making intermediates useful in the synthesis of retroviral protease inhibitors
SEARLE & CO39 citations95
US7115618B2Oct 3, 2006
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO12 citations93
US6924286B1Aug 2, 2005
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO16 citations93
US6846954B2Jan 25, 2005
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO16 citations93
US6646010B2Nov 11, 2003
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO16 citations93
US6417387B1Jul 9, 2002
α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO24 citations93
US6046190AApr 4, 2000
Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
SEARLE & CO43 citations93
US6875790B2Apr 5, 2005
Cyclic sulfone containing retroviral protease inhibitors
SEARLE & CO16 citations92
US7141609B2Nov 28, 2006
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO13 citations84
US5849784ADec 15, 1998
Cyclic sulfone containing retroviral protease inhibitors
SEARLE & CO13 citations82
US6265583B1Jul 24, 2001
Cyclic sulfone containing retroviral protease inhibitors
SEARLE & CO6 citations74
US5622949AApr 22, 1997
Retroviral protease inhibitors
SEARLE & CO12 citations74
US5872298AFeb 16, 1999
Method of preparing intermediates for retroviral protease inhibitors
SEARLE & CO5 citations73
US5698569ADec 16, 1997
Retroviral protease inhibitors
SEARLE & CO3 citations63
US5620977AApr 15, 1997
Retroviral protease inhibitors
SEARLE & CO3 citations63
US5872299AFeb 16, 1999
Method of preparing intermediates for retroviral protease inhibitors
SEARLE & CO4 citations62
MONSANTO CO
5 patentsUS5475013ADec 12, 1995
Retroviral protease inhibitors
MONSANTO CO31 citations93
US6552203B2Apr 22, 2003
Cyclic sulfone containing retroviral protease inhibitors
MONSANTO CO16 citations92
US5514801AMay 7, 1996
Cyclic sulfone containing retroviral protease inhibitors
MONSANTO CO14 citations82
US7112683B2Sep 26, 2006
Cyclic sulfone containing retroviral protease inhibitors
MONSANTO CO6 citations74
US6329524B1Dec 11, 2001
Cyclic sulfone containing retroviral protease inhibitors
MONSANTO CO3 citations74
SEARLE LLC
4 patentsUS7320983B2Jan 22, 2008
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE LLC8 citations82
US7829564B2Nov 9, 2010
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE LLC4 citations74
US7531538B2May 12, 2009
α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE LLC6 citations74
USRE42889ENov 1, 2011
α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE LLC2 citations63